128 related articles for article (PubMed ID: 3008711)
1. Metabolic and contractile changes in ischaemic rat hearts after isoproterenol administration: effect of reperfusion.
Bartel S; Krause EG; Karczewski P
Biomed Biochim Acta; 1986; 45(1-2):S215-8. PubMed ID: 3008711
[TBL] [Abstract][Full Text] [Related]
2. Effects of verapamil on myocardial contractility, cardiac adenosine 3,'5'-monophosphate and heart phosphorylase.
Shanfeld J; Hess ME; Levine NR
J Pharmacol Exp Ther; 1975 May; 193(2):317-26. PubMed ID: 167148
[TBL] [Abstract][Full Text] [Related]
3. Effect of isoproterenol on protein phosphorylation in myocardial ischaemia.
Krause EG; England PJ
Gen Physiol Biophys; 1984 Jun; 3(3):193-9. PubMed ID: 6479578
[TBL] [Abstract][Full Text] [Related]
4. Metabolic and inotropic effects of verapamil in perfused rat heart.
Hess ME; Shanfeld J; Levine NR
Recent Adv Stud Cardiac Struct Metab; 1975; 10():81-8. PubMed ID: 174169
[TBL] [Abstract][Full Text] [Related]
5. Enhanced contractile response and protein kinase activation to threshold levels of beta-adrenergic stimulation in hyperthyroid rat heart.
Guarnieri T; Filburn CR; Beard ES; Lakatta EG
J Clin Invest; 1980 Apr; 65(4):861-8. PubMed ID: 6102099
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
[TBL] [Abstract][Full Text] [Related]
7. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
[TBL] [Abstract][Full Text] [Related]
8. The effect of dobutamine on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
McNeill JH
Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):597-600. PubMed ID: 209506
[TBL] [Abstract][Full Text] [Related]
9. Role of protein kinase and contractile force in the regulation of myocardial lipolysis.
Rabin RA; Allen DO
Horm Metab Res; 1984 Sep; 16(9):465-7. PubMed ID: 6094327
[TBL] [Abstract][Full Text] [Related]
10. Transient activation of cyclic AMP-dependent protein kinase and phosphorylase during the cardiac cycle in the canine myocardium in situ and the effect of propranolol.
Krause EG; Bartel S; Ameln I; Beyerdörfer I; Freier W; Reese D
Biomed Biochim Acta; 1987; 46(8-9):S482-6. PubMed ID: 2829869
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin E1 activation of heart cAMP-dependent protein kinase: apparent dissociation of protein kinase activation from increases in phosphorylase activity and contractile force.
Keely SL
Mol Pharmacol; 1979 Mar; 15(2):235-45. PubMed ID: 89626
[No Abstract] [Full Text] [Related]
12. Anion manipulation, a novel antiarrhythmic approach: mechanism of action.
Curtis MJ; Garlick PB; Ridley PD
J Mol Cell Cardiol; 1993 Apr; 25(4):417-36. PubMed ID: 8393492
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of isoproterenol and 4-deoxypyridoxine effects on the isovolumic rat heart model.
Lorenzato M; Millart H; Albert O
In Vivo; 1990; 4(3):195-9. PubMed ID: 1966802
[TBL] [Abstract][Full Text] [Related]
15. Interaction between alpha and beta adrenergic receptors and cholinergic receptors in isolated perfused rat heart: effects on cAMP-protein kinase and phosphorylase.
Ingebretsen CG
J Cyclic Nucleotide Res; 1980; 6(2):121-32. PubMed ID: 6251120
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the cardiac phosphorylase activating effect of dibutyryl cyclic AMP by thyroid hormone.
McNeill JH
Res Commun Chem Pathol Pharmacol; 1977 Apr; 16(4):735-43. PubMed ID: 193168
[TBL] [Abstract][Full Text] [Related]
17. Coronary venous drug infusion in the ischaemic-reperfused isolated rat heart.
Uriuda Y; Wang QD; Li XS; Sjoquist PO; Nordlander R; Ryden L
Cardiovasc Res; 1996 Jan; 31(1):82-92. PubMed ID: 8849592
[TBL] [Abstract][Full Text] [Related]
18. The effect of glucagon on rat cardiac cyclic AMP, phosphorylase a and force of contraction.
Brunt ME; McNeill JH
Arch Int Pharmacodyn Ther; 1978 May; 233(1):42-52. PubMed ID: 210728
[TBL] [Abstract][Full Text] [Related]
19. Cyclic GMP-dependent protein kinase activation in the absence of negative inotropic effects in the rat ventricle.
MacDonell KL; Diamond J
Br J Pharmacol; 1997 Dec; 122(7):1425-35. PubMed ID: 9421291
[TBL] [Abstract][Full Text] [Related]
20. Actions and interactions of theophylline and imidazole on cardiac contractility, phosphorylase activation and cyclic AMP.
Verma SC; McNeill JH
Arch Int Pharmacodyn Ther; 1976 May; 221(1):4-8. PubMed ID: 183614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
